{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T17:14:17Z","timestamp":1740158057040,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T00:00:00Z","timestamp":1620000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T00:00:00Z","timestamp":1620000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS099160","NS099783","9R01NS096785-06"],"award-info":[{"award-number":["NS099160","NS099783","9R01NS096785-06"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["BX000355","BX003824"],"award-info":[{"award-number":["BX000355","BX003824"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32-HL125242","T32-GM007863","HL108842"],"award-info":[{"award-number":["T32-HL125242","T32-GM007863","HL108842"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["20PRE35110083"],"award-info":[{"award-number":["20PRE35110083"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl. Stroke Res."],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s12975-021-00908-2","type":"journal-article","created":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T10:02:58Z","timestamp":1620036178000},"page":"1081-1092","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Electrophilic and Drug-Induced Stimulation of NOTCH3 N-terminal Fragment Oligomerization in Cerebrovascular Pathology"],"prefix":"10.1007","volume":"12","author":[{"given":"K. Z.","family":"Young","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. M. P.","family":"Cartee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. G.","family":"Keep","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. I.","family":"Ivanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael M.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,3]]},"reference":[{"key":"908_CR1","doi-asserted-by":"crossref","unstructured":"Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature. 1996;383:707\u201310.","DOI":"10.1038\/383707a0"},{"key":"908_CR2","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.biocel.2011.08.005","volume":"43","author":"MM Wang","year":"2011","unstructured":"Wang MM. Notch signaling and Notch signaling modifiers. Int J Biochem Cell Biol. 2011;43:1550\u201362.","journal-title":"Int J Biochem Cell Biol"},{"key":"908_CR3","doi-asserted-by":"crossref","unstructured":"Young KZ, Lee SJ, Zhang X, Cartee NMP, Torres M, Keep SG, et al. NOTCH3 is non-enzymatically fragmented in inherited cerebral small-vessel disease. 2020;295:jbc.RA119.007724\u20131972.","DOI":"10.1074\/jbc.RA119.007724"},{"key":"908_CR4","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1093\/hmg\/ddp211","volume":"18","author":"C Opherk","year":"2009","unstructured":"Opherk C, Duering M, Peters N, Karpinska A, Rosner S, Schneider E, et al. CADASIL mutations enhance spontaneous multimerization of NOTCH3. Hum Mol Genet. 2009;18:2761\u20137.","journal-title":"Hum Mol Genet"},{"key":"908_CR5","doi-asserted-by":"crossref","unstructured":"Duering M, Karpinska A, Rosner S, Hopfner F, Zechmeister M, Peters N, et al. Co-aggregate formation of CADASIL-mutant NOTCH3: a single-particle analysis. Hum Mol Genet [Internet]. 2011;20:3256\u201365. Available from: https:\/\/academic.oup.com\/hmg\/article-lookup\/doi\/10.1093\/hmg\/ddr237.","DOI":"10.1093\/hmg\/ddr237"},{"key":"908_CR6","doi-asserted-by":"publisher","first-page":"113261","DOI":"10.1016\/j.expneurol.2020.113261","volume":"328","author":"KZ Young","year":"2020","unstructured":"Young KZ, Cartee NMP, Ivanova MI, Wang MM. Thiol-mediated and catecholamine-enhanced multimerization of a cerebrovascular disease enriched fragment of NOTCH3. Exp Neurol. 2020;328:113261.","journal-title":"Exp Neurol"},{"key":"908_CR7","doi-asserted-by":"crossref","unstructured":"Mykk\u00e4nen K, Junna M, Amberla K, Bronge L, K\u00e4\u00e4ri\u00e4inen H, P\u00f6yh\u00f6nen M, et al. Different clinical phenotypes in monozygotic CADASIL twins with a novel NOTCH3 mutation. Stroke. 2009;40:2215\u20138.","DOI":"10.1161\/STROKEAHA.108.528661"},{"key":"908_CR8","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s12975-011-0112-2","volume":"3","author":"X Zhang","year":"2012","unstructured":"Zhang X, Meng H, Blaivas M, Rushing EJ, Moore BE, Schwartz J, et al. Von Willebrand Factor permeates small vessels in CADASIL and inhibits smooth muscle gene expression. Transl Stroke Res. 2012;3:138\u201345.","journal-title":"Transl Stroke Res"},{"key":"908_CR9","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1016\/0006-2952(82)90161-7","volume":"31","author":"S Ito","year":"1982","unstructured":"Ito S, Fujita K. Conjugation of dopa and 5-S-cysteinyldopa with cysteine mediated by superoxide radical. Biochem Pharmacol. 1982;31:2887\u20139.","journal-title":"Biochem Pharmacol"},{"key":"908_CR10","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.redox.2015.08.005","volume":"6","author":"K Wojdyla","year":"2015","unstructured":"Wojdyla K, Rogowska-Wrzesinska A. Differential alkylation-based redox proteomics\u2013Lessons learnt. Redox Biol. 2015;6:240\u201352.","journal-title":"Redox Biol"},{"key":"908_CR11","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s12551-016-0218-6","volume":"8","author":"J Stetefeld","year":"2016","unstructured":"Stetefeld J, McKenna SA, Patel TR. Dynamic light scattering: a practical guide and applications in biomedical sciences. Biophys Rev. 2016;8:409\u201327.","journal-title":"Biophys Rev"},{"key":"908_CR12","doi-asserted-by":"crossref","unstructured":"Jameson RF, Linert W, Tschinkowitz A, Gutmann V. Anaerobic oxidation of cysteine to cystine by iron(III). Part 1. The reaction in acidic solution. J Chem Soc Dalton Trans. 1988;943\u20136.","DOI":"10.1039\/dt9880000943"},{"key":"908_CR13","doi-asserted-by":"crossref","unstructured":"Brogden RN, Markham A. Fenoldopam: a review of its pharmacodynamic and pharmacokinetic properties and intravenous clinical potential in the management of hypertensive urgencies and emergencies. Drugs. 1997;54:634\u201350.","DOI":"10.2165\/00003495-199754040-00008"},{"key":"908_CR14","doi-asserted-by":"crossref","unstructured":"Shin JM, Cho YM, Sachs G. Chemistry of covalent inhibition of the gastric (H+, K+)-ATPase by proton pump inhibitors. J Am Chem Soc. 2004;126:7800\u201311.","DOI":"10.1021\/ja049607w"},{"key":"908_CR15","doi-asserted-by":"crossref","unstructured":"Cartee NMP, Wang MM. Binding of omeprazole to protein targets identified by monoclonal antibodies. Ganesan A, editor. PLOS ONE. 2020;15:e0239464.","DOI":"10.1371\/journal.pone.0239464"},{"key":"908_CR16","unstructured":"National Center for Biotechnology Information. PubChem compound summary for CID 4594, Omeprazole. Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Omeprazole. Accessed 28 April 2021."},{"key":"908_CR17","unstructured":"National Center for Biotechnology Information. PubChem compound sfor CID 636411, Tenatoprazole. Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Tenatoprazole. Accessed 28 April 2021."},{"key":"908_CR18","doi-asserted-by":"crossref","unstructured":"Bagchi S, Fredriksson R, Wall\u00e9n-Mackenzie \u00c5. In situ proximity ligation assay (PLA). Methods Mol Biol. 2015;1318:149\u201359.","DOI":"10.1007\/978-1-4939-2742-5_15"},{"key":"908_CR19","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1126\/science.1063522","volume":"294","author":"KA Conway","year":"2001","unstructured":"Conway KA, Rochet JC, Bieganski RM, Lansbury PT. Kinetic stabilization of the alpha-synucleinprotofibril by a dopamine-alpha-synuclein adduct. Science. 2001;294:1346\u20139.","journal-title":"Science"},{"key":"908_CR20","doi-asserted-by":"crossref","unstructured":"Lei Z, Chen XD, Mercad\u00e9-Prieto R. Effect of N-Ethylmaleimide as a blocker of disulfide crosslinks formation on the alkali-cold gelation of whey proteins. Yousefi R, editor. PLOS ONE. 2016;11:e0164496.","DOI":"10.1371\/journal.pone.0164496"},{"key":"908_CR21","doi-asserted-by":"crossref","unstructured":"Zhang P, Tang A, Zhu B, Zhu L, Zeng H. Hierarchical self-assembly of dopamine into patterned structures. Adv Mater Interfaces. 2017;4:1601218.","DOI":"10.1002\/admi.201601218"},{"key":"908_CR22","doi-asserted-by":"crossref","unstructured":"Ge C, Wang H, Zhang B, Yao J, Li X, Feng W, et al. A thiol-thiosulfonate reaction providing a novel strategy for turn-on thiol sensing. Chem Commun (Camb). 2015;51:14913\u20136.","DOI":"10.1039\/C5CC05390K"},{"key":"908_CR23","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1111\/jgh.13750","volume":"32","author":"R Batchelor","year":"2017","unstructured":"Batchelor R, Gilmartin JF-M, Kemp W, Hopper I, Liew D. Dementia, cognitive impairment and proton pump inhibitor therapy: a systematic review. J Gastroenterol Hepatol. 2017;32:1426\u201335.","journal-title":"J Gastroenterol Hepatol"},{"key":"908_CR24","doi-asserted-by":"crossref","unstructured":"Cooksey R, Kennedy J, Dennis MS, Escott-Price V, Lyons RA, Seaborne M, et al. Proton pump inhibitors and dementia risk: evidence from a cohort study using linked routinely collected national health data in Wales, UK. PLOS ONE. 2020;15:e0237676.","DOI":"10.1371\/journal.pone.0237676"},{"key":"908_CR25","doi-asserted-by":"crossref","unstructured":"Yibirin M, De Oliveira D, Valera R, Plitt AE, Lutgen S. Adverse effects associated with proton pump inhibitor use. Cureus. 2021;13:e12759.","DOI":"10.7759\/cureus.12759"},{"key":"908_CR26","doi-asserted-by":"crossref","unstructured":"Torres-Bondia F, Dakterzada F, Galv\u00e1n L, Buti M, Besanson G, Gill E, et al. Proton pump inhibitors and the risk of Alzheimer\u2019s disease and non-Alzheimer\u2019s dementias. Sci Rep. 2020;10:21046\u20139.","DOI":"10.1038\/s41598-020-78199-0"},{"key":"908_CR27","doi-asserted-by":"publisher","first-page":"041","DOI":"10.1093\/dote\/doaa041","volume":"33","author":"M Desai","year":"2020","unstructured":"Desai M, Nutalapati V, Srinivasan S, Fathallah J, Dasari C, Chandrasekhar VT, et al. Proton pump inhibitors do not increase the risk of dementia: a systematic review and meta-analysis of prospective studies. Dis Esophagus. 2020;33:041.","journal-title":"Dis Esophagus."},{"key":"908_CR28","doi-asserted-by":"crossref","unstructured":"Roberts RF, Bengoa-Vergniory N, Alegre-Abarrategui J. Alpha-Synuclein proximity ligation assay (AS-PLA) in brain sections to probe for alpha-synuclein oligomers. Methods Mol Biol. 2019;1948:69\u201376.","DOI":"10.1007\/978-1-4939-9124-2_7"},{"key":"908_CR29","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00401-019-01961-w","volume":"137","author":"H Sekiya","year":"2019","unstructured":"Sekiya H, Kowa H, Koga H, Takata M, Satake W, Futamura N, et al. Wide distribution of alpha-synuclein oligomers in multiple system atrophy brain detected by proximity ligation. Acta Neuropathol. 2019;137:455\u201366.","journal-title":"Acta Neuropathol"},{"key":"908_CR30","doi-asserted-by":"crossref","unstructured":"Rutten JW, Dauwerse HG, Gravesteijn G, van Belzen MJ, van der Grond J, Polke JM, et al. Archetypal NOTCH3 mutations frequent in public exome: implications for CADASIL. Ann Clin Transl Neurol. 2016;3:844\u201353.","DOI":"10.1002\/acn3.344"},{"key":"908_CR31","doi-asserted-by":"publisher","first-page":"e1835","DOI":"10.1212\/WNL.0000000000010525","volume":"95","author":"JW Rutten","year":"2020","unstructured":"Rutten JW, Hack RJ, Duering M, Gravesteijn G, Dauwerse JG, Overzier M, et al. Broad phenotype of cysteine-altering NOTCH3 variants in UK Biobank: CADASIL to nonpenetrance. Neurology. 2020;95:e1835\u201343.","journal-title":"Neurology"},{"key":"908_CR32","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1212\/WNL.0000000000008700","volume":"94","author":"Y-C Lee","year":"2020","unstructured":"Lee Y-C, Chung C-P, Chang M-H, Wang S-J, Liao Y-C. NOTCH3 cysteine-altering variant is an important risk factor for stroke in the Taiwanese population. Neurology. 2020;94:e87\u201396.","journal-title":"Neurology"}],"container-title":["Translational Stroke Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-021-00908-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12975-021-00908-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12975-021-00908-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,30]],"date-time":"2021-10-30T08:16:01Z","timestamp":1635581761000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12975-021-00908-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,3]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["908"],"URL":"https:\/\/doi.org\/10.1007\/s12975-021-00908-2","relation":{},"ISSN":["1868-4483","1868-601X"],"issn-type":[{"type":"print","value":"1868-4483"},{"type":"electronic","value":"1868-601X"}],"subject":[],"published":{"date-parts":[[2021,5,3]]},"assertion":[{"value":"26 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All human samples were from autopsy material, and review\u00a0by the University of Michigan IRB and the VA Ann Arbor Research and Development Committee determined that the activities described did not\u00a0require IRB approval. This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}